+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mycophenolate"

Graft versus host disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
From
From
From
LUPKYNIS Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LUPKYNIS Market Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Mycophenolate is a drug used in the treatment of hematological diseases, such as aplastic anemia, myelodysplastic syndrome, and certain types of leukemia. It is an immunosuppressant, meaning it suppresses the body's immune system, which can help reduce the risk of rejection of transplanted organs. Mycophenolate is also used to treat autoimmune diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. Mycophenolate is available in both oral and intravenous forms, and is typically prescribed in combination with other drugs. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. It is important to note that mycophenolate can cause serious side effects, including an increased risk of infection and an increased risk of certain types of cancer. The mycophenolate market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Teva Pharmaceuticals. Show Less Read more